Inventor
KOJIMA TAKUTO
JP27 patents
⚠️ This page may combine multiple inventors who share the name “KOJIMA TAKUTO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TAKEDA PHARMACEUTICALS CO
25 patentsUS10548899B2Feb 4, 2020
Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activity
TAKEDA PHARMACEUTICALS CO7 citations84
US10428056B2Oct 1, 2019
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO4 citations84
US10323027B2Jun 18, 2019
2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor
TAKEDA PHARMACEUTICALS CO4 citations84
US10087150B2Oct 2, 2018
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO5 citations84
US10053456B2Aug 21, 2018
Cyclopropanamine compound and use thereof
TAKEDA PHARMACEUTICALS CO3 citations84
US9878989B2Jan 30, 2018
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO7 citations84
US9718814B2Aug 1, 2017
Cyclopropanamine compound and use thereof
TAKEDA PHARMACEUTICALS CO5 citations84
US9714241B2Jul 25, 2017
Cyclopropanamine compound and use thereof
TAKEDA PHARMACEUTICALS CO5 citations84
US9487511B2Nov 8, 2016
Cyclopropanamine compound and use thereof
TAKEDA PHARMACEUTICALS CO5 citations84
US9751885B2Sep 5, 2017
Cyclopropanamine compound and use thereof
TAKEDA PHARMACEUTICALS CO15 citations83
US10899752B2Jan 26, 2021
2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor
TAKEDA PHARMACEUTICALS CO1 citations73
US10208046B2Feb 19, 2019
Nitrogen-containing heterocyclic compound
TAKEDA PHARMACEUTICALS CO4 citations73
US9777005B2Oct 3, 2017
Bicyclic heterocyclic compound containing a substituted pyrrole ring
TAKEDA PHARMACEUTICALS CO5 citations73
US10981934B2Apr 20, 2021
Fused heterocyclic compound
TAKEDA PHARMACEUTICALS CO1 citations72
US10696651B2Jun 30, 2020
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO3 citations72
US10577382B2Mar 3, 2020
Fused heterocyclic compound
TAKEDA PHARMACEUTICALS CO3 citations72
US10435399B2Oct 8, 2019
HDAC6 inhibitory heterocyclic compound
TAKEDA PHARMACEUTICALS CO5 citations71
US10968213B2Apr 6, 2021
Cyclopropanamine compound and use thereof
TAKEDA PHARMACEUTICALS CO0 citations62
US11390634B2Jul 19, 2022
Fused heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations61
US10519110B2Dec 31, 2019
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO1 citations59
US10414761B2Sep 17, 2019
Cyclopropanamine compound and use thereof
TAKEDA PHARMACEUTICALS CO0 citations52
US9920047B2Mar 20, 2018
Cyclopropanamine compound and use thereof
TAKEDA PHARMACEUTICALS CO0 citations52
US12084436B2Sep 10, 2024
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations49
US10189785B2Jan 29, 2019
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations49
US10676461B2Jun 9, 2020
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations43